New Medications in the Treatment of Acute Decompensated Heart Failure.

about

New Medications in the Treatment of Acute Decompensated Heart Failure.

Item

http://www.wikidata.org/entity/Q52629414

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

New Medications in the Treatment of Acute Decompensated Heart Failure.

@en

New Medications in the Treatment of Acute Decompensated Heart Failure.

@nl

type

Item

label

New Medications in the Treatment of Acute Decompensated Heart Failure.

@en

New Medications in the Treatment of Acute Decompensated Heart Failure.

@nl

prefLabel

New Medications in the Treatment of Acute Decompensated Heart Failure.

@en

New Medications in the Treatment of Acute Decompensated Heart Failure.

@nl

P1476

New Medications in the Treatment of Acute Decompensated Heart Failure

@en

P2093

Ryan Dahn

http://www.w3.org/2001/XMLSchema#string

P2860

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.

Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association.

Acute decompensated heart failure update.

Ultrafiltration in decompensated heart failure with cardiorenal syndrome.

Cardiovascular effects of urocortin 2 and urocortin 3 in patients with chronic heart failure.

Intracoronary Gene Transfer of Adenylyl Cyclase 6 in Patients With Heart Failure: A Randomized Clinical Trial

Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure.

Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure: The ATOMIC-AHF Study.

Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial.

P304

85-87

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0018578717750096

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Scot Walker

P577

2017-12-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29581599

http://www.w3.org/2001/XMLSchema#string

P932

5863887

http://www.w3.org/2001/XMLSchema#string